{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:18:17Z","timestamp":1786997897254,"version":"build-2736575974"},"reference-count":39,"publisher":"Elsevier BV","issue":"22","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100011094","name":"Public Health Agency of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011094","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.vaccine.2024.04.050","type":"journal-article","created":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T17:01:29Z","timestamp":1713373289000},"page":"125904","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Exploring COVID-19 vaccine uptake and hesitancy among vulnerable populations in inner city Vancouver, Canada: Insights into characteristics and clinical outcomes"],"prefix":"10.1016","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3899-5205","authenticated-orcid":false,"given":"Saina","family":"Beitari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shana","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shawn","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rossitta","family":"Yung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Conway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.vaccine.2024.04.050_b0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellin.2022.100029","article-title":"Emerging SARS-CoV-2 variants: Why, how, and what\u2019s next?","volume":"1","author":"Chen","year":"2022","journal-title":"Cell Insight"},{"key":"10.1016\/j.vaccine.2024.04.050_b0010","doi-asserted-by":"crossref","DOI":"10.1038\/s41579-022-00841-7","article-title":"SARS-CoV-2 variant biology: immune escape, transmission and fitness","author":"Carabelli","year":"2023","journal-title":"Nat Rev Microbiol"},{"issue":"1","key":"10.1016\/j.vaccine.2024.04.050_b0015","first-page":"157","article-title":"WHO Declares COVID-19 a Pandemic","volume":"91","author":"Cucinotta","year":"2020","journal-title":"Acta Biomed"},{"key":"10.1016\/j.vaccine.2024.04.050_b0020","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.ijid.2021.11.009","article-title":"Real-world effectiveness of COVID-19 vaccines: a literature review and meta-analysis","volume":"114","author":"Zheng","year":"2022","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.vaccine.2024.04.050_b0025","article-title":"Effectiveness of BNT162b2 and mRNA-1273 covid-19 vaccines against symptomatic SARS-CoV-2 infection and severe covid-19 outcomes in Ontario, Canada: test negative design study","volume":"20","author":"Chung","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2024.04.050_b0030","unstructured":"History of Immunization in BC. 2023. http:\/\/www.bccdc.ca\/resource-gallery\/Documents\/Guidelines%20and%20Forms\/Guidelines%20and%20Manuals\/Epid\/CD%20Manual\/Chapter%202%20-%20Imms\/HistoryImmunization.pdf."},{"key":"10.1016\/j.vaccine.2024.04.050_b0035","unstructured":"Vancouver Health Authority rolls out COVID-19 vaccine on downtown eastside. 2021. CBC. https:\/\/www.cbc.ca\/news\/canada\/british-columbia\/vancouver-health-authority-rolls-out-covid-19-vaccine-on-downtown-eastside-1.5895158#:\u223c:text=British%20Columbia-,Vancouver%20health%20authority%20rolls%20out%20COVID%2D19%20vaccine%20on%20Downtown,2%20of%20its%20immunization%20plan."},{"key":"10.1016\/j.vaccine.2024.04.050_b0040","first-page":"11","article-title":"Racial and ethnic disparities in COVID-19 booster vaccination among U.S. older adults differ by geographic region and Medicare enrollment. Front","author":"Hayes","year":"2023","journal-title":"Public Health"},{"issue":"6","key":"10.1016\/j.vaccine.2024.04.050_b0045","doi-asserted-by":"crossref","first-page":"E1075","DOI":"10.9778\/cmajo.20230026","article-title":"Racial disparities in COVID-19 vaccination in Canada: results from the cross-sectional Canadian Community Health Survey","volume":"11","author":"Guay","year":"2023","journal-title":"CMAJ Open"},{"issue":"1","key":"10.1016\/j.vaccine.2024.04.050_b0050","doi-asserted-by":"crossref","first-page":"17930","DOI":"10.1038\/s41598-023-44069-8","article-title":"Uptake of SARS-CoV-2 vaccination among structurally-marginalized people who use drugs in Vancouver, Canada","volume":"13","author":"Reddon","year":"2023","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.vaccine.2024.04.050_b0055","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41380-020-00880-7","article-title":"COVID-19 risk and outcomes in patients with substance use disorders: analyses from electronic health records in the United States","volume":"26","author":"Wang","year":"2021","journal-title":"Mol Psychiatry"},{"issue":"11","key":"10.1016\/j.vaccine.2024.04.050_b0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0260286","article-title":"Prevalence and correlates of SARS-CoV-2 seropositivity among people who inject drugs in the San Diego-Tijuana border region","volume":"16","author":"Strathdee","year":"2021","journal-title":"PLoS One"},{"issue":"26","key":"10.1016\/j.vaccine.2024.04.050_b0065","doi-asserted-by":"crossref","first-page":"E716","DOI":"10.1503\/cmaj.200834","article-title":"COVID-19 and people experiencing homelessness: challenges and mitigation strategies","volume":"192","author":"Perri","year":"2020","journal-title":"Can Med Assoc J"},{"key":"10.1016\/j.vaccine.2024.04.050_b0070","doi-asserted-by":"crossref","unstructured":"Vasylyeva TI, Smyrnov P, Strathdee S, Friedman SR. Challenges posed by COVID\u201019 to people who inject drugs and lessons from other outbreaks. J Int AIDS Soc. 2020 Jul 22;23(7).","DOI":"10.1002\/jia2.25583"},{"issue":"1","key":"10.1016\/j.vaccine.2024.04.050_b0075","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s12954-023-00826-6","article-title":"Identifying barriers and facilitators to COVID-19 vaccination uptake among People Who Use Drugs in Canada: a National Qualitative Study","volume":"20","author":"Ali","year":"2023","journal-title":"Harm Reduct J"},{"issue":"2","key":"10.1016\/j.vaccine.2024.04.050_b0080","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.pec.2021.09.006","article-title":"Applying harm reduction to COVID-19 prevention: The influence of moderation messages and risk infographics","volume":"105","author":"Kemp","year":"2022","journal-title":"Patient Educ Couns"},{"key":"10.1016\/j.vaccine.2024.04.050_b0085","unstructured":"United Nations Office on Drugs and Crime [Internet]. Tailoring vaccination campaigns and COVID-19 services for people who use drugs. 2022. https:\/\/www.unodc.org\/documents\/hiv-aids\/2022\/22-10822_eBook_2.pdf."},{"key":"10.1016\/j.vaccine.2024.04.050_b0090","unstructured":"Harm Reduction Coalition.COVID-19 Resources. 2022. https:\/\/harmreduction.org\/our-work\/action\/covid-19-harm-reduction-response\/."},{"issue":"12","key":"10.1016\/j.vaccine.2024.04.050_b0095","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.3390\/vaccines10122044","article-title":"Understanding Vaccine Perceptions and Willingness to Receive COVID-19 Vaccination: Opportunities to Strengthen Public Health Responses and COVID-19 Services for People Who Use Drugs","volume":"10","author":"Jordan","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.vaccine.2024.04.050_b0100","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.drugalcdep.2019.01.037","article-title":"Strategies used by people who inject drugs to avoid stigma in healthcare settings","volume":"198","author":"Biancarelli","year":"2019","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.vaccine.2024.04.050_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2023.104157","article-title":"Challenges of implementing safer supply programs in Canada during the COVID-19 pandemic: A qualitative analysis","volume":"120","author":"Karamouzian","year":"2023","journal-title":"Int J Drug Policy"},{"key":"10.1016\/j.vaccine.2024.04.050_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2023.104212","article-title":"Negative changes in illicit drug supply during COVID-19: Associations with use of overdose prevention and health services among women sex workers who use drugs (2020\u20132021)","volume":"121","author":"Moreheart","year":"2023","journal-title":"Int J Drug Policy"},{"issue":"1","key":"10.1016\/j.vaccine.2024.04.050_b0115","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12913-023-09028-z","article-title":"Disruptions of sexually transmitted and blood borne infections testing services during the COVID-19 pandemic: accounts of service providers in Ontario, Canada","volume":"23","author":"Ryu","year":"2023","journal-title":"BMC Health Serv Res"},{"issue":"2","key":"10.1016\/j.vaccine.2024.04.050_b0120","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3138\/canlivj.1.2.002","article-title":"Diagnosis and treatment of hepatitis C virus infection: a tool for engagement with people who inject drugs in Vancouver\u2019s Downtown Eastside","volume":"1","author":"Alimohammadi","year":"2018","journal-title":"Canadian Liver J"},{"key":"10.1016\/j.vaccine.2024.04.050_b0125","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.drugpo.2019.05.024","article-title":"Low rate of reinfection among a cohort of people who use drugs successfully treated for hepatitis C virus infection in Vancouver","volume":"72","author":"Holeksa","year":"2019","journal-title":"Canada Int J Drug Policy"},{"key":"10.1016\/j.vaccine.2024.04.050_b0130","unstructured":"Government of Canada [Internet]. 2023. COVID-19 vaccination: Vaccination coverage."},{"issue":"1","key":"10.1016\/j.vaccine.2024.04.050_b0135","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/jrh.12442","article-title":"COVID-19 during the opioid epidemic \u2013 exacerbation of stigma and vulnerabilities","volume":"37","author":"Jenkins","year":"2021","journal-title":"J Rural Health"},{"issue":"3","key":"10.1016\/j.vaccine.2024.04.050_b0140","doi-asserted-by":"crossref","first-page":"e24709","DOI":"10.1016\/j.heliyon.2024.e24709","article-title":"Does education influence COVID-19 vaccination? A global view","volume":"10","author":"Lupu","year":"2024","journal-title":"Heliyon"},{"issue":"10","key":"10.1016\/j.vaccine.2024.04.050_b0145","doi-asserted-by":"crossref","first-page":"2776","DOI":"10.1007\/s10461-020-02925-y","article-title":"Disinformation, misinformation and inequality-driven mistrust in the time of COVID-19: lessons unlearned from AIDS denialism","volume":"24","author":"Jaiswal","year":"2020","journal-title":"AIDS Behav"},{"issue":"4","key":"10.1016\/j.vaccine.2024.04.050_b0150","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1080\/15332640.2017.1292418","article-title":"Perceived discrimination among racial and ethnic minority drug users and the association with health care utilization","volume":"16","author":"McKnight","year":"2017","journal-title":"J Ethn Subst Abuse"},{"issue":"S2","key":"10.1016\/j.vaccine.2024.04.050_b0155","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/1475-6773.13852","article-title":"Racial Disparities in Access to Potential <scp>COVID<\/scp> -19 Vaccine Administration Facilities across <scp>US<\/scp> States: A Geographic Information Systems Analysis","volume":"56","author":"Guo","year":"2021","journal-title":"Health Serv Res"},{"issue":"5","key":"10.1016\/j.vaccine.2024.04.050_b0160","doi-asserted-by":"crossref","first-page":"e110","DOI":"10.1016\/S1473-3099(20)30724-6","article-title":"Intention to vaccinate against COVID-19 in Australia","volume":"21","author":"Rhodes","year":"2021","journal-title":"Lancet Infect Dis"},{"issue":"49","key":"10.1016\/j.vaccine.2024.04.050_b0165","doi-asserted-by":"crossref","first-page":"7789","DOI":"10.1016\/j.vaccine.2020.10.027","article-title":"Parents\u2019 and guardians\u2019 views on the acceptability of a future COVID-19 vaccine: A multi-methods study in England","volume":"38","author":"Bell","year":"2020","journal-title":"Vaccine"},{"issue":"48","key":"10.1016\/j.vaccine.2024.04.050_b0170","doi-asserted-by":"crossref","first-page":"7668","DOI":"10.1016\/j.vaccine.2020.09.084","article-title":"Caregiver willingness to vaccinate their children against COVID-19: Cross sectional survey","volume":"38","author":"Goldman","year":"2020","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2024.04.050_b0175","doi-asserted-by":"crossref","first-page":"e726","DOI":"10.1093\/cid\/ciab975","article-title":"Correlates of coronavirus disease 2019 (COVID-19) vaccine hesitancy among people who inject drugs in the San Diego-Tijuana Border Region","volume":"75","author":"Strathdee","year":"2022","journal-title":"Clin Infect Dis"},{"issue":"20","key":"10.1016\/j.vaccine.2024.04.050_b0180","first-page":"2000","article-title":"substance use disorders and COVID-19 vaccine response","volume":"326","author":"Rubin","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2024.04.050_b0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2021.108812","article-title":"COVID-19 vaccine trust among clients in a sample of California residential substance use treatment programs","volume":"225","author":"Masson","year":"2021","journal-title":"Drug Alcohol Depend"},{"issue":"4","key":"10.1016\/j.vaccine.2024.04.050_b0190","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1177\/0268580920914755","article-title":"COVID-19 infodemic: More retweets for science-based information on coronavirus than for false information","volume":"35","author":"Pulido","year":"2020","journal-title":"Int Sociol"},{"issue":"10","key":"10.1016\/j.vaccine.2024.04.050_b0195","doi-asserted-by":"crossref","DOI":"10.1098\/rsos.201199","article-title":"Susceptibility to misinformation about COVID-19 around the world","volume":"7","author":"Roozenbeek","year":"2020","journal-title":"R Soc Open Sci"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24004778?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24004778?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T17:08:13Z","timestamp":1737565693000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X24004778"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":39,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S0264410X24004778"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.04.050","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring COVID-19 vaccine uptake and hesitancy among vulnerable populations in inner city Vancouver, Canada: Insights into characteristics and clinical outcomes","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.04.050","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"125904"}}